» Articles » PMID: 12631658

Promoter Methylation of E-cadherin Gene in Gastric Mucosa Associated with Helicobacter Pylori Infection and in Gastric Cancer

Overview
Journal Gut
Specialty Gastroenterology
Date 2003 Mar 13
PMID 12631658
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: E-cadherin is an adhesion molecule involved in tumour invasion/metastasis. Silencing of E-cadherin by promoter CpG methylation has been shown in both familial and sporadic gastric cancers. Helicobacter pylori is a class I carcinogen in gastric cancer.

Aims: This study was undertaken to investigate the association between methylation of E-cadherin and H pylori in gastric mucosa from dyspeptic patients, and in intestinal metaplasia and primary and metastatic adenocarcinoma from surgical specimens of patients with gastric cancer.

Methods: E-cadherin methylation was studied using methylation specific polymerase chain reaction in microdissected tissue from biopsies or surgical resection specimens. E-cadherin expression was studied by immunohistochemistry.

Results: E-cadherin methylation was present in 31% (11/35) of gastric mucosae from dyspeptic patients, and was associated with H pylori infection (p=0.002), but was independent of the age of the patient or presence or absence of gastritis. E-cadherin methylation was present in 0% (0/8) of normal mucosa, 57% (12/21) of intestinal metaplasias, and 58% (15/26) of primary and 65% (21/32) of metastatic cancers. E-cadherin methylation status was concordant in 92% (11/12) of intestinal metaplasias and primary cancers, and in 85% (17/20) of primary and metastatic cancers from the same resected specimen. E-cadherin methylation in gastric cancer was associated with depth of tumour invasion (p=0.02) and regional nodal metastasis (p=0.05).

Conclusion: E-cadherin methylation is an early event in gastric carcinogenesis, and is initiated by H pylori infection.

Citing Articles

Role of E-cadherin in epithelial barrier dysfunction: implications for bacterial infection, inflammation, and disease pathogenesis.

Lialios P, Alimperti S Front Cell Infect Microbiol. 2025; 15:1506636.

PMID: 40007608 PMC: 11850337. DOI: 10.3389/fcimb.2025.1506636.


Gut microbiota in cancer initiation, development and therapy.

Zhang R, Zhang X, Lau H, Yu J Sci China Life Sci. 2025; .

PMID: 39821827 DOI: 10.1007/s11427-024-2831-x.


Detection of CDH1 gene promoter hypermethylation in gastric cancer and chronic gastritis.

Bayat M, Shirgir A, Kazemi Veisari A, Najjar Sadeghi R Pract Lab Med. 2024; 40:e00406.

PMID: 38883562 PMC: 11180341. DOI: 10.1016/j.plabm.2024.e00406.


Gastric Epithelial Barrier Disruption, Inflammation and Oncogenic Signal Transduction by Helicobacter pylori.

Naumann M, Ferino L, Sharafutdinov I, Backert S Curr Top Microbiol Immunol. 2024; 444:207-238.

PMID: 38231220 DOI: 10.1007/978-3-031-47331-9_8.


EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.

Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.

PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.


References
1.
Chan A, Lam S, Chu K, Lam C, Kwok E, Leung S . Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut. 2001; 48(6):808-11. PMC: 1728335. DOI: 10.1136/gut.48.6.808. View

2.
Fang J, Mikovits J, Bagni R, Ruscetti F . Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation. J Virol. 2001; 75(20):9753-61. PMC: 114547. DOI: 10.1128/JVI.75.20.9753-9761.2001. View

3.
Usadel H, Brabender J, Danenberg K, Jeronimo C, Harden S, Engles J . Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res. 2002; 62(2):371-5. View

4.
Knudson Jr A . Contribution and mechanisms of genetic predisposition to cancer: hereditary cancers and anti-oncogenes. Prog Clin Biol Res. 1983; 132C:351-60. View

5.
Correa P . A human model of gastric carcinogenesis. Cancer Res. 1988; 48(13):3554-60. View